Olpha

Executive Summary

Olpha is a private European pharmaceutical manufacturer based in Vienna, founded in 2018, specializing in small molecule drugs and active pharmaceutical ingredients (APIs). The company operates across the full value chain from R&D to contract manufacturing, with a product portfolio spanning over a dozen therapeutic areas and serving more than 60 global markets. Its mission is to provide accessible, quality healthcare. As a relatively young company, Olpha has established a broad product reach and a presence in multiple markets. However, limited public information on financials, pipeline, or specific growth milestones makes it difficult to assess near-term trajectory. The company's success hinges on securing manufacturing contracts, expanding its API offerings, and navigating regulatory landscapes. While no immediate catalysts are identifiable, Olpha's integrated model and European base position it for steady, albeit potentially unspectacular, growth in the generic and contract manufacturing sectors.